Form 8-K · Current report
News Corp 8-K, filed Oct 2, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000214
Summary
News Corp disclosed daily buy-back activity to the Australian Securities Exchange under its 2025 Repurchase Program, which authorizes up to US$1 billion of its Nasdaq-listed Class A and Class B common stock. The company repurchased 62,323 shares on October 1, 2026 for about US$1.77 million, bringing total purchases under the program to roughly US$509.5 million.
Key points
- News Corp reported 12,671,326 shares bought back before the previous day and 62,323 shares bought back on October 1, 2026.
- Total consideration paid under the program to date is approximately US$509,481,234 of the US$1 billion authorized.
- Prices paid under the program have ranged from US$22.20 to US$31.58 per share.
- The program covers Class A and Class B common stock; no ASX-listed CDIs will be repurchased.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.